HomeBusiness NewsTelix secures $73m deal to acquire US biotech ImaginAb

Telix secures $73m deal to acquire US biotech ImaginAb

January 13, 2025

- Advertisement -

Melbourne-based biotech Telix Pharmaceuticals (ASX: TLX) is planning to expand its suite of next-generation drug candidates through the acquisition of US-based antibody engineering company ImaginAb for US$45 million ($73 million).

The deal could be worth up to a total of…

Click here to view the original article.

Tags
Businessnewsaus.com.au

- Advertisment -

Limited-run, track-ready Mazda MX-5 revealed

Police arrest 15yo boy over alleged machete attack and attempted robbery in St Kilda

Telix secures $73m deal to acquire US biotech ImaginAb

Recently Viewed

Brisbane legacy beyond the Games: Plan to transform unused space ahead of 2032 and build 50,000 new homes

He built a business running through Sydney, before Meta froze his account

Shooting for the stars: Old Ways New Ways netball team shines on and off the cour…

A journalist examines populist protests against AI and data centers

FEATURED

Great White shark bites fishing boat off Sunshine Coast

Volcanic cloud from Whakaari White Island halts flights

Great Koala Count: Aussies urged to track sightings of iconic marsupials

POPULAR POSTS

Queensland government takes on Andrew Forrest’s Fortescue in bid to claw back $66 million

Opportunity for first-time buyers with sale of Paddy's Lakes in SA

Constance Brément: From Cannes Yachting Festival exhibitor to show organiser

POPULAR CATEGORY

FOLLOW US

Telix secures $73m deal to acquire US biotech ImaginAb

RELATED ARTICLES

Recently Viewed

FEATURED

POPULAR POSTS

POPULAR CATEGORY

FOLLOW US